Status:
COMPLETED
Monitoring Spondyloarthritis With SpA-Net
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Maastricht University
Medisch Spectrum Twente
Conditions:
Spondyloarthritis
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Randomized controlled trial to assess the effectiveness and cost-effectiveness of an intervention combining patient initiated care and telemonitoring through the online eHealth platform SpA-Net versus...
Detailed Description
Multicenter randomized controlled trial to investigate the effectiveness and cost-effectiveness of telemonitoring through SpA-Net, in combination with patient initiated care, versus standard care. Par...
Eligibility Criteria
Inclusion
- Adult patient (18+ years)
- Diagnosis of SpA according to treating physician
- At least 2 years of disease duration, to be familiar with signs, symptoms, and medication
- Stable disease, defined as being in a patient acceptable symptom state according to patient AND treating physician AND no treatment change expected in the next few months
- Access to a computer, tablet and/or smartphone for the entire duration of the study
Exclusion
- Insufficient mastery of Dutch language
- Incompetent to act for oneself
- Limited life expectancy
- Ongoing (or planned) pregnancy during the study period
- Patients participating in other research project(s)
Key Trial Info
Start Date :
December 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04673825
Start Date
December 2 2020
End Date
July 1 2023
Last Update
August 8 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6229 HX
2
Medisch Spectrum Twente
Enschede, Overijssel, Netherlands